Adient
ADNT
14.48
-0.60
-3.98%
Adient
US · ADNT
#3061 by market cap
Listed 2016
14.48
-0.60
-3.98%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Adient (ADNT) Gets a Buy From J.P. MorganTipRanks · 2026/10/3
-
Rating change
Citi Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $29Market Newswire · 2026/8/11
-
A Quick Look at Today's Ratings for Adient(ADNT.US), With a Forecast Between $22 to $23Market Newswire · 2026/11/6
-
Rating change
Barclays Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $25Market Newswire · 2026/8/10
-
Rating change
Morgan Stanley Maintains Adient(ADNT.US) With Hold Rating, Raises Target Price to $21Market Newswire · 2026/8/18
-
Rating change
J.P. Morgan Upgrades Adient(ADNT.US) to Buy Rating, Cuts Target Price to $25Market Newswire · 2026/9/15
-
Rating change
Stifel Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $21Market Newswire · 2026/10/19
-
Rating change
J.P. Morgan Maintains Adient(ADNT.US) With Buy Rating, Maintains Target Price $25Market Newswire · 2026/10/3
-
Citi Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $27Market Newswire · 2026/11/6
-
Morgan Stanley Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $19Market Newswire · 2026/11/6
-
Rating change
UBS Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $23Market Newswire · 2026/10/7
-
Rating change
A Quick Look at Today's Ratings for Adient(ADNT.US), With a Forecast Between $26 to $29Market Newswire · 2026/8/7
-
Rating change
UBS Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $29Market Newswire · 2026/8/6
-
Rating change
Barclays Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $22Market Newswire · 2026/10/9
-
Rating change
Stifel Maintains Adient(ADNT.US) With Buy Rating, Maintains Target Price $26Market Newswire · 2026/8/6
-
Rating change
Wells Fargo Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $29Market Newswire · 2026/8/6
-
Rating change
J.P. Morgan Initiates Adient(ADNT.US) With Hold Rating, Announces Target Price $28Market Newswire · 2026/8/10
-
Rating change
Adient (ADNT) Was Upgraded to a Buy Rating at J.P. MorganTipRanks · 2026/9/15
-
Barclays Maintains Adient(ADNT.US) With Hold Rating, Maintains Target Price $22Market Newswire · 2026/11/7
-
J.P. Morgan Maintains Adient(ADNT.US) With Buy Rating, Maintains Target Price $23Market Newswire · 2026/11/10
-
Rating change
BNP Paribas Initiates Adient(ADNT.US) With Buy Rating, Announces Target Price $26Market Newswire · 2026/7/30
-
Rating change
Stifel Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $26Market Newswire · 2026/7/20
-
Rating change
J.P. Morgan Remains a Hold on Adient (ADNT)TipRanks · 2026/7/12
-
Rating change
UBS Maintains Adient(ADNT.US) With Buy Rating, Raises Target Price to $34Market Newswire · 2026/7/9
-
Rating change
BofA Securities Maintains Adient(ADNT.US) With Sell RatingMarket Newswire · 2026/7/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Adient discussion 0 comments